Block listing Interim Review

RNS Number : 6144J
Hikma Pharmaceuticals Plc
14 April 2020
 

Hikma Pharmaceuticals PLC

 

 

Block Listing Six Monthly Return

 

Date: 14 April 2020

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")

 

Period of return

From:

1 October 2019

To:

31 March 2020

Balance of unallotted securities under scheme(s) from previous return:

SOP: 792,700 ordinary shares of 10 pence

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

SOP: 0 ordinary shares of 10 pence

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

SOP: 0 ordinary shares of 10 pence

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

SOP: 792,700 ordinary shares of 10 pence

 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

 

 

Block Listing Six Monthly Return

 

Date: 14 April 2020

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")

Period of return

From:

1 October 2019

To:

31 March 2020

Balance of unallotted securities under scheme(s) from previous return:

LTIP: 102,714 ordinary shares of 10 pence

 

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

LTIP: 0 ordinary shares of 10 pence

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

LTIP: 15,014 ordinary shares of 10 pence

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

LTIP: 87,700 ordinary shares of 10 pence

 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

 

Block Listing Six Monthly Return

 

Date: 14 April 2020

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP")

Period of return

From:

1 October 2019

To:

31 March 2020

Balance of unallotted securities under scheme(s) from previous return:

MIP: 770,393 ordinary shares of 10 pence

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

MIP: 1,000,000 ordinary shares of 10 pence

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

MIP: 8,391 ordinary shares of 10 pence

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

MIP: 1,519,989 ordinary shares of 10 pence

 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

 

Block Listing Six Monthly Return

 

Date: 14 April 2020

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP")

Period of return

From:

1 October 2019

To:

31 March 2020

Balance of unallotted securities under scheme(s) from previous return:

EIP: 1,541,128 ordinary shares of 10 pence

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

EIP: 0 ordinary shares of 10 pence

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

EIP:  8,742 ordinary shares of 10 pence

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

EIP: 1,102,558 ordinary shares of 10 pence

 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

 

LEI: 549300BNS685UXH4JI75

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRGPUBPCUPUGWC
UK 100

Latest directors dealings